ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.58
1.25%
US Tech 100
20,913.60
1.69%
S&P 500
5,950.33
1.42%
US Dollar vs CAD
1.43565
-0.33%
Bitcoin
97,233.57
-0.23%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Clearside Biomedical Inc (CLSD)

  7. Clearside Biomedical Inc (CLSD) News

CLSD

Clearside Biomedical (CLSD)

Clearside Biomedical Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CLSD
DateTimeSourceHeadlineSymbolCompany
12/19/20246:05AMGlobeNewswire Inc.Clearside Biomedical Announces Publication of Critical Insights into Retinal Drug Development in the Peer-Reviewed Scientific Journal, EyeNASDAQ:CLSDClearside Biomedical Inc
11/25/20246:05AMGlobeNewswire Inc.Clearside Biomedical Extends Global Footprint with Numerous Presentations at Medical Meetings in Asia, Europe and the United StatesNASDAQ:CLSDClearside Biomedical Inc
11/12/20243:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
11/12/20243:05PMGlobeNewswire Inc.Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
11/07/20248:05AMGlobeNewswire Inc.Clearside Biomedical Partner Arctic Vision Executes Commercial Collaboration Agreement with Santen Pharmaceutical Co., Ltd for ARVN001 Suprachoroidal Space Injection Therapy for the Treatment of Uveitic Macular EdemaNASDAQ:CLSDClearside Biomedical Inc
11/06/20246:05AMGlobeNewswire Inc.Clearside Biomedical to Participate in Fireside Chat at the Stifel 2024 Healthcare ConferenceNASDAQ:CLSDClearside Biomedical Inc
11/04/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CLSDClearside Biomedical Inc
11/04/20246:05AMGlobeNewswire Inc.Clearside Biomedical Appoints Tony Gibney as New Chair of the Board of DirectorsNASDAQ:CLSDClearside Biomedical Inc
10/31/20246:05AMGlobeNewswire Inc.Clearside Biomedical to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Tuesday, November 12, 2024NASDAQ:CLSDClearside Biomedical Inc
10/22/20246:05AMGlobeNewswire Inc.Clearside Biomedical’s Positive ODYSSEY Wet AMD Data and Suprachoroidal Injection Platform Highlighted in Presentations at Multiple Events During AAO 2024 Annual MeetingNASDAQ:CLSDClearside Biomedical Inc
10/09/20246:55AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
10/09/20245:30AMGlobeNewswire Inc.Clearside Biomedical Announces Positive Topline Results from ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX in Wet AMD Achieving All Primary and Secondary OutcomesNASDAQ:CLSDClearside Biomedical Inc
08/27/20246:05AMGlobeNewswire Inc.Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMDNASDAQ:CLSDClearside Biomedical Inc
08/12/20243:30PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CLSDClearside Biomedical Inc
08/12/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
08/12/20243:05PMGlobeNewswire Inc.Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
08/08/20246:05AMGlobeNewswire Inc.Clearside Biomedical to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual ConferenceNASDAQ:CLSDClearside Biomedical Inc
08/01/20246:05AMGlobeNewswire Inc.Clearside Biomedical to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024NASDAQ:CLSDClearside Biomedical Inc
07/29/20243:05PMGlobeNewswire Inc.Clearside Biomedical’s Partner Arctic Vision Reports Positive Topline Results from Phase 3 Clinical Trial of ARCATUS® for Suprachoroidal Use in Uveitic Macular Edema Patients in ChinaNASDAQ:CLSDClearside Biomedical Inc
07/24/20246:55AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
07/22/202411:00AMGlobeNewswire Inc.Clearside Biomedical Opens Registration for Suprachoroidal Delivery KOL Webinar to Be Held on Wednesday, July 24, 2024 at 8:00 am ETNASDAQ:CLSDClearside Biomedical Inc
07/11/20246:05AMGlobeNewswire Inc.Clearside Biomedical Appoints Dr. Glenn Yiu to its Scientific Advisory BoardNASDAQ:CLSDClearside Biomedical Inc
06/27/20246:05AMGlobeNewswire Inc.Clearside Biomedical to Host Virtual Key Opinion Leader Event on the Use and Versatility of Suprachoroidal Drug DeliveryNASDAQ:CLSDClearside Biomedical Inc
06/12/20246:05AMGlobeNewswire Inc.Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit MeetingNASDAQ:CLSDClearside Biomedical Inc
05/21/20246:05AMGlobeNewswire Inc.Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA®NASDAQ:CLSDClearside Biomedical Inc
05/10/20243:31PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CLSDClearside Biomedical Inc
05/09/20243:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
05/09/20243:05PMGlobeNewswire Inc.Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
05/08/20243:15PMGlobeNewswire Inc.Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences ConferenceNASDAQ:CLSDClearside Biomedical Inc
04/30/20246:05AMGlobeNewswire Inc.Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024NASDAQ:CLSDClearside Biomedical Inc
 Showing the most relevant articles for your search:NASDAQ:CLSD

Your Recent History

USOTC
RDAR
Raadr (PK)
COIN
SHIBUSD
SHIBA INU
USOTC
BCDS
BlaqClouds (PK)
USOTC
MGON
Megola (PK)
USOTC
MVNT
Movement Industries (PK)
USOTC
CBRF
CyberFuels (PK)
NASDAQ
NUKK
Nukkleus
NASDAQ
NXPL
NextPlat
USOTC
AFFU
Affluence (PK)
USOTC
GTCH
GBT Technologies (PK)
NASDAQ
NB
NioCorp Developments
USOTC
PHIL
PHI (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
SPZI
Spooz (PK)
USOTC
RDGL
Vivos (QB)
COIN
XRPUSD
Ripple
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads